Transgene Biotek Limited (BOM:526139)
India · Delayed Price · Currency is INR 2.560
-0.090 (-3.40%)
At close: Apr 13, 2026
Transgene Biotek Market Cap
Transgene Biotek has a market cap or net worth of 200.79 million as of April 15, 2026. Its market cap has decreased by -25.56% in one year.
Market Cap
200.79M
Enterprise Value
365.23M
Revenue
2.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.56
Market Cap Chart
Since January 3, 2005, Transgene Biotek's market cap has decreased from 1.43B to 200.79M, a decrease of -85.97%. That is a compound annual growth rate of -8.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 200.79M | -15.87% |
| Dec 31, 2025 | 238.68M | -53.88% |
| Dec 31, 2024 | 517.51M | -30.80% |
| Dec 29, 2023 | 747.85M | 234.58% |
| Dec 30, 2022 | 223.52M | -33.71% |
| Dec 31, 2021 | 337.18M | -8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maxgrow India | 201.94M |
| Amin Tannery | 201.91M |
| Max Heights Infrastructure | 201.52M |
| Mewar Hi-Tech Engineering | 201.43M |
| RGF Capital Markets | 201.03M |
| Easun Capital Markets | 201.01M |
| Shree Metalloys | 201.00M |
| IITL Projects | 200.73M |